Browse
Browse and Search
Search
Explore more content
12865_2021_473_MOESM1_ESM.
docx
(70.12 kB)
File info
This item contains files with download restrictions
Fullscreen
Additional file 1 of Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
Cite
Download
(70.12 kB)
Share
Embed
journal contribution
posted on 2021-12-26, 04:07
authored by
Fabien Francois
,
Loubna Naimi
,
Xavier Roblin
,
Anne-Emmanuelle Berger
,
Stephane Paul
Additional file 1. Supplementary datas.
History
Usage metrics
Categories
Space Science
Medicine
Molecular Biology
Biotechnology
Environmental Sciences not elsewhere classified
Ecology
Immunology
Cancer
Science Policy
Hematology
Keywords
Anti-TNFα
Adalimumab
Biosimilar
ABP501
AMGEVITA
HUMIRA
Drug monitoring
Licence
CC BY + CC0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC